Background
Respiratory acidosis is a clinical disturbance due to alveolar hypoventilation. Production of carbon dioxide occurs rapidly and failure of ventilation promptly increases the partial arterial pressure of carbon dioxide (PaCO2).[1] The normal reference range for PaCO2 is 35-45 mm Hg.
Alveolar hypoventilation leads to an increased PaCO2 (ie, hypercapnia). The increase in PaCO2, in turn, decreases the bicarbonate (HCO3-) / PaCO2 ratio, thereby decreasing the pH. Hypercapnia and respiratory acidosis ensue when impairment in ventilation occurs and the removal of carbon dioxide by the lungs is less than the production of carbon dioxide in the tissues.
Acute and chronic respiratory acidosis
Respiratory acidosis can be acute or chronic. In acute respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range (ie, > 45 mm Hg) with an accompanying acidemia (ie, pH < 7.35). In chronic respiratory acidosis, the PaCO2 is elevated above the upper limit of the reference range, with a normal or near-normal pH secondary to renal compensation and an elevated serum bicarbonate value (ie, > 30 meq/L).
Acute respiratory acidosis is present when an abrupt failure of ventilation occurs. This failure in ventilation may be caused by depression of the central respiratory center by: (1) cerebral disease or drugs, (2) an inability to ventilate adequately owing to a neuromuscular disease (eg, myasthenia gravis, amyotrophic lateral sclerosis, Guillain-Barré syndrome, muscular dystrophy), or (3) airway obstruction usually related to asthma or chronic obstructive pulmonary disease (COPD).
Chronic respiratory acidosis may be secondary to many disorders, including COPD. Hypoventilation in COPD involves multiple mechanisms, including: (1) decreased responsiveness to hypoxia and hypercapnia, (2) increased ventilation-perfusion mismatch leading to increased dead space ventilation, and (3) decreased diaphragmatic function due to fatigue and hyperinflation.
Chronic respiratory acidosis also may be secondary to obesity hypoventilation syndrome (ie, pickwickian syndrome), neuromuscular disorders such as amyotrophic lateral sclerosis (ALS), and severe restrictive ventilatory defects as observed in interstitial fibrosis and thoracic skeletal deformities.
Lung diseases that primarily cause abnormalities in alveolar gas exchange usually do not cause hypoventilation; however, they tend to cause stimulation of ventilation and hypocapnia secondary to hypoxia. Hypercapnia typically occurs with severe pulmonary disease or when respiratory muscle fatigue is present.
See also Pediatric Respiratory Acidosis, Metabolic Acidosis, and Pediatric Metabolic Acidosis.
Etiology and Pathophysiology
As noted in Background, respiratory acidosis may occur due to a variety of etiologies, including the following:
- Chronic obstructive pulmonary disease (COPD) – Emphysema, chronic bronchitis, severe asthma[2, 3]
- Neuromuscular diseases – Amyotrophic lateral sclerosis (ALS), diaphragm dysfunction and paralysis, Guillain-Barré syndrome, myasthenia gravis, muscular dystrophy, botulism
- Chest wall disorders – Severe kyphoscoliosis, status post thoracoplasty, flail chest, and, less commonly, ankylosing spondylitis, pectus excavatum,[4] or pectus carinatum
- Obesity hypoventilation syndrome
- Obstructive sleep apnea
- Central nervous system (CNS) depression – Drugs (eg, narcotics, barbiturates, benzodiazepines, other CNS depressants), neurologic disorders (eg, encephalitis, brainstem disease, trauma), primary alveolar hypoventilation, congenital central alveolar hypoventilation syndrome (Ondine curse)
- Other lung and airway diseases – Laryngeal and tracheal stenosis
- Lung-protective mechanical ventilation with permissive hypercapnea in the treatment of acute respiratory distress syndrome (These patients are typically heavily sedated and may require paralytic agents.)
Metabolism
Metabolism rapidly generates a large quantity of volatile acid (carbon dioxide) and nonvolatile acid. The metabolism of fats and carbohydrates leads to the formation of a large amount of carbon dioxide. The carbon dioxide combines with water to form carbonic acid (H2 CO3). The lungs excrete the volatile fraction through ventilation, and normally acid accumulation does not occur. A significant alteration in ventilation that affects elimination of carbon dioxide can cause a respiratory acid-base disorder. The partial arterial pressure of carbon dioxide (PaCO2) is normally maintained within the range of 35 to 45 mm Hg.[5, 6]
Alveolar ventilation
Alveolar ventilation is under the control of the central respiratory centers, which are located in the pons and the medulla. Ventilation is influenced and regulated by chemoreceptors for PaCO2, partial arterial pressure of oxygen (PaO2), and pH located in the brainstem, as well as by neural impulses from lung-stretch receptors and impulses from the cerebral cortex. Failure of ventilation quickly results in an increase in the PaCO2.
Physiologic compensation
In acute respiratory acidosis, the body's compensation occurs in 2 steps. The initial response is cellular buffering that takes places over minutes to hours. Cellular buffering elevates plasma bicarbonate values, but only slightly, approximately 1 mEq/L for each 10-mm Hg increase in PaCO2. The second step is renal compensation that occurs over 3-5 days. With renal compensation, renal excretion of carbonic acid is increased and bicarbonate reabsorption is increased.
Estimated change in serum bicarbonate and pH levels
The expected change in serum bicarbonate concentration in respiratory acidosis can be estimated as follows:
- Acute respiratory acidosis: Bicarbonate increases 1 mEq/L for each 10-mm Hg rise in PaCO2 (The acute change in bicarbonate is, therefore, relatively modest. It is generated by the blood, extracellular fluid, and cellular buffering system.)
- Chronic respiratory acidosis: Bicarbonate increases 3.5 mEq/L for each 10-mm Hg rise in PaCO2 (The greater change in bicarbonate in chronic respiratory acidosis is accomplished by the kidneys. The response begins soon after the onset of respiratory acidosis but requires 3-5 days to become complete.)
The expected change in pH with respiratory acidosis can be estimated with the following equations:
- Acute respiratory acidosis: Change in pH = 0.008 × (40 – PaCO2)
- Chronic respiratory acidosis: Change in pH = 0.003 × (40 – PaCO2)
Electrolyte levels
Respiratory acidosis does not have a great effect on electrolyte levels. Some small effects occur in calcium and potassium levels. Acidosis decreases binding of calcium to albumin and tends to increase serum ionized calcium levels. In addition, acidemia causes an extracellular shift of potassium. Respiratory acidosis, however, rarely causes clinically significant hyperkalemia.
Murray J, Nadel J. Hypoventilation syndromes. In: Textbook of Respiratory Medicine. Vol 2. 4th ed. Philadelphia, Pa: WB Saunders; 2005:2075-80.
Adnet F, Plaisance P, Borron SW, Levy A, Payen D. Prolonged severe hypercapnia complicating near fatal asthma in a 35-year-old woman. Intensive Care Med. Dec 1998;24(12):1335-8. [Medline].
Cham GW, Tan WP, Earnest A, Soh CH. Clinical predictors of acute respiratory acidosis during exacerbation of asthma and chronic obstructive pulmonary disease. Eur J Emerg Med. Sep 2002;9(3):225-32. [Medline].
Theerthakarai R, El-Halees W, Javadpoor S, Khan MA. Severe pectus excavatum associated with cor pulmonale and chronic respiratory acidosis in a young woman. Chest. Jun 2001;119(6):1957-61. [Medline].
Ehrsam RE, Heigenhauser GJ, Jones NL. Effect of respiratory acidosis on metabolism in exercise. J Appl Physiol. Jul 1982;53(1):63-9. [Medline].
Kazmaier S, Weyland A, Buhre W, et al. Effects of respiratory alkalosis and acidosis on myocardial blood flow and metabolism in patients with coronary artery disease. Anesthesiology. Oct 1998;89(4):831-7. [Medline].
Wu JY, Kuo PH, Fan PC, Wu HD, Shih FY, Yang PC. The Role of Non-invasive Ventilation and Factors Predicting Extubation Outcome in Myasthenic Crisis. Neurocrit Care. 2009;10(1):35-42. [Medline].
Zhang WB, Wang XY, Tian XY, Zhang H, Wang ZP, Gao YY. [Clinical value of noninvasive positive-pressure ventilation in chronic obstruction pulmonary disease combined with type II respiratory failure: a 4-year retrospective study]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. Oct 2008;20(10):601-3. [Medline].
Terragni PP, Birocco A, Faggiano C, Ranieri VM. Extracorporeal CO(2) Removal. Contrib Nephrol [serial online]. 2010 April 20;165:185-196. [Medline]. Available at http://-.
Ali A, Flageole H. Diaphragmatic pacing for the treatment of congenital central alveolar hypoventilation syndrome. J Pediatr Surg. May 2008;43(5):792-6. [Medline].
Pollock JM, Deibler AR, Whitlow CT, et al. Hypercapnia-Induced Cerebral Hyperperfusion: An Underrecognized Clinical Entity. AJNR Am J Neuroradiol. Oct 14 2008;[Medline].
Duiverman ML, Wempe JB, Bladder G, et al. Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax. Dec 2008;63(12):1052-7. [Medline].
Kellum JA. Determinants of plasma acid-base balance. Crit Care Clin. Apr 2005;21(2):329-46. [Medline].
Wiseman AC, Linas S. Disorders of potassium and acid-base balance. Am J Kidney Dis. May 2005;45(5):941-9. [Medline].

